These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 29543535)

  • 1. Vaccination strategies for the prevention of meningococcal disease.
    Vuocolo S; Balmer P; Gruber WC; Jansen KU; Anderson AS; Perez JL; York LJ
    Hum Vaccin Immunother; 2018 May; 14(5):1203-1215. PubMed ID: 29543535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public policy for meningococcal vaccination.
    Cameron JC
    Hum Vaccin Immunother; 2018 May; 14(5):1216-1217. PubMed ID: 29194013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of meningococcal vaccination on carriage and disease transmission: A review of the literature.
    Balmer P; Burman C; Serra L; York LJ
    Hum Vaccin Immunother; 2018 May; 14(5):1118-1130. PubMed ID: 29565712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving meningococcal immunization strategies.
    Sáfadi MA; Bettinger JA; Maturana GM; Enwere G; Borrow R;
    Expert Rev Vaccines; 2015 Apr; 14(4):505-17. PubMed ID: 25494168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of the Epidemiology of Invasive Meningococcal Disease and Vaccination Strategies in North Africa.
    Taha MK; Presa J; Serra L
    Int J Infect Dis; 2021 Mar; 104():189-197. PubMed ID: 33227521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges.
    Mustapha MM; Harrison LH
    Hum Vaccin Immunother; 2018 May; 14(5):1107-1115. PubMed ID: 29211624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges and opportunities for meningococcal vaccination in the developing world.
    Shaker R; Fayad D; Dbaibo G
    Hum Vaccin Immunother; 2018 May; 14(5):1084-1097. PubMed ID: 29393729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation.
    Caro JJ; Möller J; Getsios D; Coudeville L; El-Hadi W; Chevat C; Nguyen VH; Caro I
    BMC Public Health; 2007 Jun; 7():130. PubMed ID: 17603880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection.
    Borrow R; Alarcón P; Carlos J; Caugant DA; Christensen H; Debbag R; De Wals P; Echániz-Aviles G; Findlow J; Head C; Holt D; Kamiya H; Saha SK; Sidorenko S; Taha MK; Trotter C; Vázquez Moreno JA; von Gottberg A; Sáfadi MA;
    Expert Rev Vaccines; 2017 Apr; 16(4):313-328. PubMed ID: 27820969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal disease in New Zealand.
    Mills G; Bell A
    N Z Med J; 2013 Apr; 126(1373):10-1. PubMed ID: 23797072
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations.
    Baker CJ
    J Adolesc Health; 2016 Aug; 59(2 Suppl):S29-37. PubMed ID: 27449147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of vaccination on meningococcal epidemiology.
    Stefanelli P; Rezza G
    Hum Vaccin Immunother; 2016 Apr; 12(4):1051-5. PubMed ID: 26512927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meningococcal vaccination in pregnancy.
    Abu Raya B; Sadarangani M
    Hum Vaccin Immunother; 2018 May; 14(5):1188-1196. PubMed ID: 29485347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surveillance for meningococcal disease and strategies for use of conjugate meningococcal vaccines in the United States.
    Lingappa JR; Rosenstein N; Zell ER; Shutt KA; Schuchat A; Perkins BA;
    Vaccine; 2001 Aug; 19(31):4566-75. PubMed ID: 11483285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of group B meningococcal disease by vaccination: a difficult task.
    Thomas M
    N Z Med J; 2004 Aug; 117(1200):U1016. PubMed ID: 15475986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of meningococcal C conjugate vaccination programs with and without catch-up campaigns in adolescents: Lessons learned from Bahia, Brazil.
    Evellyn do Macedo L; Ferreira VM; Feitosa CA; Nunes AMPB; Campos LC; Sáfadi MAP
    Hum Vaccin Immunother; 2018 May; 14(5):1131-1137. PubMed ID: 29236585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.
    Villena R; Safadi MAP; Valenzuela MT; Torres JP; Finn A; O'Ryan M
    Hum Vaccin Immunother; 2018 May; 14(5):1042-1057. PubMed ID: 29667483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.
    Sáfadi MA; McIntosh ED
    Expert Rev Vaccines; 2011 Dec; 10(12):1717-30. PubMed ID: 22085175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Balocchini E; Canessa C; Azzari C; Bonanni P
    Vaccine; 2012 Oct; 30(45):6396-401. PubMed ID: 22921931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serogroup B meningococcal disease: new outbreaks, new strategies.
    Wenger JD
    JAMA; 1999 Apr; 281(16):1541-3. PubMed ID: 10227326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.